Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-03

Clinical Trial Update: Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing intravesical glycosaminoglycan instillation for urinary tract infection in acute spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The University of Western Australia | Conditions: Spinal Cord Injuries | Phase 1, Phase 2 | Status: COMPLETED